#Sweden #Integrum AB #OPRA Implant #Mölndal #BondedMatrix

Integrum Launches an Innovative Global Marketing Strategy

Integrum AB, a trailblazer in the medical technology field, recently showcased a groundbreaking global marketing strategy at the American Orthotic Prosthetic Association's (AOPA) National Assembly held in Orlando, Florida. This pivotal event marked a significant step for Integrum as they introduced their new branding concept, BondedMatrix™, linked to their renowned OPRA™ Implant System.

Understanding BondedMatrix™

The newly coined term BondedMatrix™ encapsulates the OPRA Implant System's unique ability to create a lasting connection between soft tissue and bone. This innovative design is crucial for delivering long-term benefits to patients and healthcare professionals alike. The term aims to simplify communication about the benefits of the OPRA system globally, making it easier for both clinicians and patients to understand the advantages of this advanced technology.

According to Jeffrey Zanni, the President of Integrum Inc., this new marketing initiative aims to establish a unified language around the OPRA Implant System. He emphasized that creating a common understanding of the BondedMatrix will empower healthcare professionals and patients in their discussions, ensuring clarity around the advanced features of their innovative solution in the realm of bone-anchored prosthetics.

A Strong Foundation in Innovation

The OPRA Implant System has been at the forefront of medical technology since its inception, with significant contributions from Rickard Brånemark, MD, the inventor of the OPRA system, who has been refining the surgical techniques since 1990. As of now, over 1,000 OPRA implants have been successfully integrated worldwide, assisting amputees in regaining independence and mobility.

Dr. Jason Souza, the director of the Advanced Amputation Program at Ohio State University and a leading figure in the field of bone-anchored prosthetics, remarked on the reliability of the BondedMatrix™ interface. He stated, “Patients are looking for a dependable and dry skin-implant interface—something only the OPRA Implant System can reliably deliver.” This emphasis on dependability echoes the transformative impact that Integrum aims to provide through their OPRA implants.

Engaging with the Community

Integrum's presence at AOPA 2025 is not just about introducing BondedMatrix™; it's also about engaging with the medical community. At booth #931, attendees will find live discussions and educational resources aimed at bridging knowledge gaps regarding the OPRA system and its benefits.

Furthermore, on Thursday evening, Integrum will host an educational dinner featuring insights from Dr. Souza, who will discuss patient outcomes and share clinical experiences with the OPRA system and BondedMatrix™. This initiative reflects Integrum’s commitment to fostering partnerships and equipping clinicians with the necessary knowledge to better serve their patients.

Conclusion

Integrum AB’s Bold marketing strategy encapsulated in BondedMatrix™ is more than just a branding endeavor; it symbolizes a paradigm shift in how bone-anchored prosthetic solutions are communicated to clinicians and patients alike. By promoting clarity and understanding, Integrum is not only refining its market approach but also enhancing the lives of countless individuals who rely on their innovative technologies for improved mobility and quality of life. For further insights into BondedMatrix™, visit www.bondedmatrix.com.